Scoles DR, Meera P, Schneider MD, Paul S, Dansithong W, Figueroa KP, Hung G, Rigo F, Bennett CF, Otis TS, Pulst SM (2017) Antisense oligonucleotide therapy for spinocerebellar ataxia type 2
Mendoza-Viveros et al., 2017
Subchronic and chronic toxicity studies extending up to several months of continuous BPC-157 administration reveal no significant organ toxicity, hematological abnormalities, or pathological changes in treated animals compared to controls
MR scan assessors were blinded to participant group allocation
Since the ELISA is offered in a standard 96-well format, it is also possible to determine genetic segregations as data from plate readers can be quickly analyzed by statistical software